HBM Healthcare Investments Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
389
- Portfolio
-
54
- Exits
-
197
HBM Healthcare Investments General Information
Company Description
Founded in 2001, HBM Healthcare Investments is a venture capital firm based in Zug, Switzerland. The firm seeks to invest in companies operating in the human medicine, biotechnology, pharma, drug development, healthcare services, life sciences, medical technology, and diagnostics sectors across Europe, Asia, and North America.
Business Details
Website
www.hbmhealthcare.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Bundesplatz 1
- 6300 Zug
- Switzerland
HBM Healthcare Investments Investments & Acquisitions (389)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Antiva Biosciences | 11-Oct-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| OneSource (Healthcare Services) | 26-Sep-2024 | Other Healthcare Services | Generating Revenue | |||
| Egenesis | 04-Sep-2024 | Biotechnology | Pre-Clinical Trials | |||
| Odyssey Therapeutics | 14-Aug-2024 | Biotechnology | Pre-Clinical Trials | |||
| Cartesian Therapeutics | 08-Aug-2024 | Biotechnology | Generating Revenue/Not Profitable | |||
| Chemomab Therapeutics | 30-Jul-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Mahzi Therapeutics | 21-Jun-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Flerie | 10-Jun-2024 | Private Equity | Generating Revenue/Not Profitable | |||
| Biopas Group | 31-May-2024 | Buyout/LBO | Pharmaceuticals | Generating Revenue | ||
| Alumis | 29-May-2024 | Later Stage VC | Drug Discovery | Generating Revenue |
HBM Healthcare Investments Exits (197)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Gynesonics | 11-Oct-2024 | Merger/Acquisition | |
| Upstream Bio | 11-Oct-2024 | ||
| Chope | 22-Jul-2024 | ||
| Ark Jianke Group | 09-Jul-2024 | ||
| Alumis | 28-Jun-2024 | ||
| Ambrx | 07-Mar-2024 | ||
| ArriVent Biopharma | 26-Jan-2024 | ||
| i-Optics | 01-Nov-2023 | ||
| Chinook Therapeutics | 11-Aug-2023 | Merger/Acquisition | |
| IVERIC bio | 11-Jul-2023 | Merger/Acquisition |
HBM Healthcare Investments Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
HBM Healthcare Investments Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
HBM Healthcare Investments Co-Investors (334)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HBM Partners | 48 |
|
|
||
| Cormorant Asset Management |
|
|
|||
| RA Capital Management |
|
|
|||
| OrbiMed |
|
|
|||
| RTW Investments |
|
|
HBM Healthcare Investments FAQs
-
What is HBM Healthcare Investments?
Founded in 2001, HBM Healthcare Investments is a venture capital firm based in Zug, Switzerland.
-
When was HBM Healthcare Investments founded?
HBM Healthcare Investments was founded in 2001.
-
Where is HBM Healthcare Investments headquartered?
HBM Healthcare Investments is headquartered in Zug, Switzerland.
-
How many investments has HBM Healthcare Investments made?
HBM Healthcare Investments has made 389 investments.
-
What has HBM Healthcare Investments invested in?
HBM Healthcare Investments has made numerous investments in companies like Antiva Biosciences, OneSource (Healthcare Services), and Egenesis within the Drug Discovery, Healthcare Services, and Biotechnology industries.
-
What has HBM Healthcare Investments invested in recently?
HBM Healthcare Investments's latest investment was on 11-Oct-2024 in Antiva Biosciences, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
